The Initiative for Multipurpose Prevention Technologies (IMPT) develops tools and resources to inform MPT product development and investment decisions and to educate other interested stakeholders. .
|
Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies | |
|
This report by Dr. Betsy Tolley (FHI 360) presents learnings and reflections on traditional socio-behavioral research (SBR) and human-centered design (HCD) as applied to the global health context – specifically in biomedical prevention for sexual and reproductive health. In comparing these methodologies and examining their strengths and shortcomings, we can identify potential synergies to further inform the development and eventual introduction of MPTs in targeted end-user populations.
|
|
|
Join the MPT development collaboration | |
|
Whether your experience is in SRH prevention, drug delivery, novel formulation science, engineering, or polymer chemistry, the IMPT encourages a global collaboration among organizations who have paved the way for promising first-generation MPT products.
|
|
|
Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries |
|
Building upon the IMPT's report: "Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in development...
|
|
|
Building MPT Acceptability During Product Development Through Consumer and Health Systems Research | |
|
The IMPT aims to improve the health of adolescent girls and young women, but each individual has her own needs and preferences. It is critical for an MPT product to be both effective and acceptable to its intended population to fit these realities and constraints.
|
|
|
Building Capacity for MPT Product Development | |
|
As more products enter the pipeline and advance from pre-clinical toward clinical studies, the IMPT and its partners continue to highlight research gaps, identify regulatory requirements, and recommend strategies to accelerate MPT development.
|
|
